SCHEMBL1768335

SCHEMBL1768335

COCC(O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1768332 1.00
SCHEMBL7392053 1.00
SCHEMBL20703013 0.84 PGK1 (0.47)
SCHEMBL20703011 0.84 PGK1 (0.47)
SCHEMBL10304919 0.79
SCHEMBL6874300 0.79
SCHEMBL21645228 0.78
SCHEMBL11153518 0.78
SCHEMBL21645160 0.78
SCHEMBL3475941 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078115-A1 ALIPHATIC ACID AMIDE DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2026-03-19 US disclosed
US-12503463-B2 Aliphatic acid amide derivative Sumitomo Pharma Co., Ltd. (JP) 2025-12-23 US disclosed
EP-4082616-B1 ALIPHATIC ACID AMIDE DERIVATIVE SUMITOMO PHARMA CO LTD (JP) 2025-09-03 EP disclosed
CN-114981264-B Fatty acid amide derivatives 住友制药株式会社 2024-07-26 CN disclosed
CN-113710664-B JAK1 selective kinase inhibitors 迪哲(江苏)医药股份有限公司 2024-01-26 CN disclosed
CN-111356680-B Selective inhibitors of NLRP3 inflammasome 诺瑟拉有限公司 2023-11-28 CN disclosed
US-20230010358-A1 Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) Protein PRELUDE THERAPEUTICS, INCORPORATED 2023-01-12 US disclosed
EP-4082616-A1 ALIPHATIC ACID AMIDE DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2022-11-02 EP disclosed
CN-113105475-B Inhibitors of bruton's tyrosine kinase and methods of use thereof 詹森药业有限公司 2022-09-09 CN disclosed
CN-114981264-A Fatty acid amide derivatives 住友制药株式会社 2022-08-30 CN disclosed
EP-2501683-A1 SUBSTITUTED CARBAMOYLMETHYLAMINO ACETIC ACID DERIVATIVES AS NOVEL NEP INHIBITORS Novartis AG (CH) 2012-09-26 EP disclosed
WO-2011061271-A1 SUBSTITUTED CARBAMOYLMETHYLAMINO ACETIC ACID DERIVATIVES AS NOVEL NEP INHIBITORS NOVARTIS AG (CH) 2011-05-26 WO disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed
US-20100261701-A1 8-Substituted isoquinoline derivative and the use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2010-10-14 US disclosed
WO-2010038465-A1 8-SUBSTITUTED ISOQUINOLINE DERIVATIVE AND USE THEREOF 旭化成ファーマ株式会社 (JP) 2010-04-08 WO disclosed
US-5486398-A BACKING WITH TEXTILE PILE YARN WITH BACK FINISH HAVING POLYESTERURETHANE COPOLYMERS HOECHST AKTIENGESELLSCHAFT 1996-01-23 US disclosed
EP-0535042-B1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1995-03-29 EP disclosed
US-5348978-A Angiotensin converting enzyme inhibitors FISONS PLC (GB) 1994-09-20 US disclosed
EP-0535042-A1 ANGIOTENSIS CONVERTING ENZYME INHIBITORS. FISONS PLC (GB) 1993-04-07 EP disclosed
WO-1992000276-A2 ANGIOTENSIS CONVERTING ENZYME INHIBITORS FISONS PLC (GB) 1992-01-09 WO disclosed